It is the twentieth anniversary of the new patent act in January 2025. The post-patent (P20) era is a story of resilience, determination, and charting a course that set global ambitions, a story of finding opportunity in adversity. It is a story for case studies in business schools, in international studies, in global health efforts.

Talent Management

A diverse, summer issue with articles on topics ranging from content marketing to the role of experience in a VUCA world. Also, the latest book for Medical Reps reviewed by Prof. Vivek Hattangadi

Patient Centered Pharma – Pipe Dream or Possible?

To me, patient centricity is as fascinating a concept as it is contradictory. It is fascinating because it puts power into the hands of the patient. And it is contradictory because pharma does not like giving away power over its messages or processes. Pharma has traditionally never enjoyed interaction and has depended on ‘pushing’ messages across rather than having ‘conversations’. It probably also explains why we make do with medical reps who are not the sharpest knives in the drawer and scarcely invest in sharpening them.

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...

Marketing

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...

Policies/Sales

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...

Strategy

Do Retail Pharmacies Really Care about Patients?

The chemist shop—jammed between a chai stall and a...

Indian Oncology: An Unasked Question, the Challenges Ahead

A Brief History of Scale and an Unasked Question In...

Are Quick Remedies Keeping Patients Away from Doctors?

The recent Mint Lounge analysis captured a striking consumer...

From Tragedy to Trust: What the CDCSO Can Learn from Dr. Frances Oldham Kelsey

Abstract The U.S. Food and Drug Administration (FDA) evolved from...

Biocon’s Landmark Succession Planning: Claire Mazumdar is the Future Leader

In a landmark decision for India’s biotechnology sector, Kiran...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

Indian Pharma October 2025 Sales Data

1. Overall Market Growth & Trends (IPM Key Highlights): Robust...

Is Pharma’s Business Model like McDonald’s? ...

Is Pharma’s business model like McDonald’s? Doing things over & over again without innovation? McDonald’s is famous for its Hamburger University, a training facility at the McDonald’s Corporation global headquarters in Chicago, Illinois. It instructs high-potential restaurant managers in restaurant management. More than 5,000 students attend Hamburger University each year and over 275,000 people have graduated with a degree in Hamburgerology. Sound familiar? Pharma’s training has been on similar lines – hire people continuously and put them through the grind of mugging up essentials of drugs for diseases that the particular company sells. While the McDonald’s model is ideal for its business of replication, it has outlived its utility in healthcare and drug companies are in danger of being reduced to mere suppliers of drugs to new digital platform businesses unless they learn to innovate.